Literature DB >> 25645864

Can circulating tumor cells predict resistance in metastatic breast cancer?

Aju Mathew1, Adam M Brufsky1, Nancy E Davidson2.   

Abstract

Circulating tumor cell (CTC) enumeration provides prognostic but not predictive information for chemotherapy in metastatic breast cancer. Because CTC measurement is reproducible and allows molecular profiling, an assay to assess endocrine resistance was developed. Whether this CTC-based assay can be used to reliably select endocrine therapy must be tested. ©2015 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25645864      PMCID： PMC4694574          DOI： 10.1158/1078-0432.CCR-14-2967

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  12 in total

1.  Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

Authors:  G Thomas Budd; Massimo Cristofanilli; Mathew J Ellis; Allison Stopeck; Ernest Borden; M Craig Miller; Jeri Matera; Madeline Repollet; Gerald V Doyle; Leon W M M Terstappen; Daniel F Hayes
Journal:  Clin Cancer Res       Date:  2006-11-01       Impact factor: 12.531

Review 2.  Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

Authors:  M Ignatiadis; S-J Dawson
Journal:  Ann Oncol       Date:  2014-10-21       Impact factor: 32.976

3.  Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.

Authors:  Costanza Paoletti; Maria C Muñiz; Dafydd G Thomas; Kent A Griffith; Kelley M Kidwell; Nahomi Tokudome; Martha E Brown; Kimberly Aung; M Craig Miller; Dorothy L Blossom; Anne F Schott; N Lynn Henry; James M Rae; Mark C Connelly; David A Chianese; Daniel F Hayes
Journal:  Clin Cancer Res       Date:  2014-11-07       Impact factor: 12.531

4.  Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.

Authors:  Daniel F Hayes; Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; M Craig Miller; Jeri Matera; W Jeffrey Allard; Gerald V Doyle; Leon W W M Terstappen
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

Review 5.  Circulating tumor cells: liquid biopsy of cancer.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Clin Chem       Date:  2012-09-26       Impact factor: 8.327

6.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

7.  The search for ESR1 mutations in breast cancer.

Authors:  Steffi Oesterreich; Nancy E Davidson
Journal:  Nat Genet       Date:  2013-12       Impact factor: 38.330

8.  Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Authors:  François-Clément Bidard; Dieter J Peeters; Tanja Fehm; Franco Nolé; Rafael Gisbert-Criado; Dimitrios Mavroudis; Salvatore Grisanti; Daniele Generali; Jose A Garcia-Saenz; Justin Stebbing; Carlos Caldas; Paola Gazzaniga; Luis Manso; Rita Zamarchi; Angela Fernandez de Lascoiti; Leticia De Mattos-Arruda; Michail Ignatiadis; Ronald Lebofsky; Steven J van Laere; Franziska Meier-Stiegen; Maria-Teresa Sandri; Jose Vidal-Martinez; Eleni Politaki; Francesca Consoli; Alberto Bottini; Eduardo Diaz-Rubio; Jonathan Krell; Sarah-Jane Dawson; Cristina Raimondi; Annemie Rutten; Wolfgang Janni; Elisabetta Munzone; Vicente Carañana; Sofia Agelaki; Camillo Almici; Luc Dirix; Erich-Franz Solomayer; Laura Zorzino; Helene Johannes; Jorge S Reis-Filho; Klaus Pantel; Jean-Yves Pierga; Stefan Michiels
Journal:  Lancet Oncol       Date:  2014-03-11       Impact factor: 41.316

9.  International study on inter-reader variability for circulating tumor cells in breast cancer.

Authors:  Michail Ignatiadis; Sabine Riethdorf; François-Clement Bidard; Isabelle Vaucher; Mustapha Khazour; Françoise Rothé; Jessica Metallo; Ghizlane Rouas; Rachel E Payne; Raoul Coombes; Ingrid Teufel; Ulrich Andergassen; Stella Apostolaki; Eleni Politaki; Dimitris Mavroudis; Silvia Bessi; Marta Pestrin; Angelo Di Leo; Michael Campion; Monica Reinholz; Edith Perez; Martine Piccart; Elin Borgen; Bjorn Naume; Jose Jimenez; Claudia Aura; Laura Zorzino; Maria Cassatella; Maria Sandri; Bianca Mostert; Stefan Sleijfer; Jaco Kraan; Wolfgang Janni; Tanja Fehm; Brigitte Rack; Leon Terstappen; Madeline Repollet; Jean-Yves Pierga; Craig Miller; Christos Sotiriou; Stefan Michiels; Klaus Pantel
Journal:  Breast Cancer Res       Date:  2014-04-23       Impact factor: 6.466

10.  Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

Authors:  Jeffrey B Smerage; William E Barlow; Gabriel N Hortobagyi; Eric P Winer; Brian Leyland-Jones; Gordan Srkalovic; Sheela Tejwani; Anne F Schott; Mark A O'Rourke; Danika L Lew; Gerald V Doyle; Julie R Gralow; Robert B Livingston; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 50.717
View more
  2 in total

1.  Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells.

Authors:  Gerhard Hamilton; Barbara Rath; Sophia Holzer; Maximilian Hochmair
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 2.  The Different Facets of Liquid Biopsy: A Kaleidoscopic View.

Authors:  Zahra Eslami-S; Luis Enrique Cortés-Hernández; Laure Cayrefourcq; Catherine Alix-Panabières
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.